LRRK2 and Parkinson disease: Given the strong effect of PQ on circSLC8A1 levels, we wondered whether two known PD protective agents, the cholesterol‐reducing agent Simvastatin (Yan et al, 2018) or the known LRRK2 inhibitor PF‐06447475 alter circSLC8A1 in the opposite way.